Inflammation News and Research

RSS

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

The fact that sleep deprivation has an impact on the function of the human immune system is well known. In their latest study, the University of Helsinki research group Sleep Team has now discovered new biological links between sleep loss and the immune system. The results provide at least a partial explanation of why sleep deprivation increases the risk of cardiovascular disease and type 2 diabetes.

24 Oct 2013

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Research from Boston University School of Medicine suggests that testosterone treatment in hypogonadal (testosterone deficient) men restores normal lipid profiles and may reduce the risk of cardiovascular disease. These finding currently appear online in the International Journal of Clinical Practice.

24 Oct 2013

Inflammation causally linked to functional decline in aging

Inflammation is the common denominator of many chronic age-related diseases such as arthritis, gout, Alzheimer's, and diabetes. But according to a Yale School of Medicine study, even in the absence of a disease, inflammation can lead to serious loss of function throughout the body, reducing healthspan - that portion of our lives spent relatively free of serious illness and disability.

23 Oct 2013

Promising technique for treating eye disease proves effective in preclinical studies

A promising technique for treating human eye disease has proven effective in preclinical studies and may lead to new treatments to prevent blindness, according to experiments conducted at The Scripps Research Institute in La Jolla, California.

23 Oct 2013

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.

23 Oct 2013

COPD treatments: an interview with Professor Price, University of Aberdeen

The first thing is that we can’t cure COPD. The problem we have with COPD is that the process itself is not treatable, certainly not once it gets to the extent that it’s advanced.

22 Oct 2013

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

Researchers report that in patients with pseudocysts with viscous debris-laden fluid, endoscopic ultrasound-guided drainage by using a combination of a nasocystic drain and transmural stents improves clinical outcomes and lowers the stent occlusion rate compared with those who underwent drainage via stents alone.

22 Oct 2013

Research: Low levels of vitamin D appear to increase child's risk of anemia

Low levels of the "sunshine" vitamin D appear to increase a child's risk of anemia, according to new research led by investigators at the Johns Hopkins Children's Center. The study, published online Oct. 10 in the Journal of Pediatrics, is believed to be the first one to extensively explore the link between the two conditions in children.

22 Oct 2013

$Adalimumab may be viable treatment option for patients with refractory pediatric uveitis$

Adalimumab may be viable treatment option for patients with refractory pediatric uveitis

A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients with steroid-resistant refractory pediatric uveitis.

22 Oct 2013

UH professor awarded $1.56M NCI grant to explore preventive therapy against colon cancer

As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute to investigate the mechanistic basis for novel colon cancer prevention and therapy.

22 Oct 2013

Astrazeneca, Evotec Launch Kidney Disease Collaboration

...

21 Oct 2013

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

Regeneron Pharmaceuticals, Inc. today announced positive topline results for EYLEA® (aflibercept) Injection from the Phase 3 VIBRANT study in patients with Macular Edema following Branch Retinal Vein Occlusion (BRVO).

21 Oct 2013

Study shows significant link between low dietary fiber intake and cardiometabolic risks

A new study published in the December issue of The American Journal of Medicine shows a significant association between low dietary fiber intake and cardiometabolic risks including metabolic syndrome, cardiovascular inflammation, and obesity.

19 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

18 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

17 Oct 2013

UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

Researchers at The University of Texas Health Science Center at Houston have begun a study investigating whether a probiotic might be helpful in reducing gut inflammation in infants with colic.

17 Oct 2013

Weight loss surgery in type 2 diabetes proves more effective at optimising diabetes control

Clinical researchers from Sydney's Garvan Institute of Medical Research and St. Vincent's Hospital have shown that a form of weight loss surgery, known as 'gastric banding', brings about reversal of diabetes in some patients, and dramatic improvement of glucose tolerance in others, within 12 weeks.

16 Oct 2013

New injection device to reduce fear and pain of injecting modern medicines

...

15 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Inflammation News and Research

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Inflammation causally linked to functional decline in aging

Promising technique for treating eye disease proves effective in preclinical studies

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

COPD treatments: an interview with Professor Price, University of Aberdeen

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

Research: Low levels of vitamin D appear to increase child's risk of anemia

Adalimumab may be viable treatment option for patients with refractory pediatric uveitis

UH professor awarded $1.56M NCI grant to explore preventive therapy against colon cancer

Astrazeneca, Evotec Launch Kidney Disease Collaboration

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

Study shows significant link between low dietary fiber intake and cardiometabolic risks

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

Weight loss surgery in type 2 diabetes proves more effective at optimising diabetes control

New injection device to reduce fear and pain of injecting modern medicines

Astrazeneca Acquires Spirogen For Up To $440M

Research finding may help patients to better survive severe infectious diseases

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News